Faculty of Natural Sciences, School of Life Sciences, Keele University, Keele, ST5 5BG, UK.
Molecular Medicine Group, Faculty of Life Sciences & Medicine, School of Cancer & Pharmaceutical Sciences, Kings College London, London, UK.
Sci Rep. 2022 Jan 7;12(1):182. doi: 10.1038/s41598-021-03983-5.
Identification of cell fate-controlling lncRNAs is essential to our understanding of molecular cell biology. Here we present a human genome-scale forward-genetics approach for the identification of lncRNAs based on gene function. This approach can identify genes that play a causal role, and immediately distinguish them from those that are differentially expressed but do not affect cell function. Our genome-scale library plus next-generation-sequencing and bioinformatic approach, radically upscales the breadth and rate of functional ncRNA discovery. Human gDNA was digested to produce a lentiviral expression library containing inserts in both sense and anti-sense orientation. The library was used to transduce human Jurkat T-leukaemic cells. Cell populations were selected using continuous culture ± anti-FAS IgM, and sequencing used to identify sequences controlling cell proliferation. This strategy resulted in the identification of thousands of new sequences based solely on their function including many ncRNAs previously identified as being able to modulate cell survival or to act as key cancer regulators such as AC084816.1*, AC097103.2, AC087473.1, CASC15*, DLEU1*, ENTPD1-AS1*, HULC*, MIRLET7BHG*, PCAT-1, SChLAP1, and TP53TG1. Independent validation confirmed 4 out of 5 sequences that were identified by this strategy, conferred a striking resistance to anti-FAS IgM-induced apoptosis.
鉴定控制细胞命运的 lncRNA 对于我们理解分子细胞生物学至关重要。在这里,我们提出了一种基于基因功能的人类全基因组规模的正向遗传学方法来鉴定 lncRNA。这种方法可以鉴定出具有因果作用的基因,并立即将其与那些不影响细胞功能但表达水平不同的基因区分开来。我们的全基因组文库加下一代测序和生物信息学方法,从根本上扩大了功能 ncRNA 发现的广度和速度。用人基因组 DNA 进行酶切,产生一个包含正向和反向插入物的慢病毒表达文库。该文库用于转导人 Jurkat T 白血病细胞。使用连续培养加抗 Fas IgM 对细胞群体进行选择,并测序以鉴定控制细胞增殖的序列。这种策略仅基于其功能鉴定了数千个新序列,包括许多先前被鉴定为能够调节细胞存活或作为关键癌症调节剂的 ncRNA,如 AC084816.1*、AC097103.2、AC087473.1、CASC15*、DLEU1*、ENTPD1-AS1*、HULC*、MIRLET7BHG*、PCAT-1、SChLAP1 和 TP53TG1。独立验证证实了通过该策略鉴定的 5 个序列中的 4 个赋予了抗 Fas IgM 诱导的细胞凋亡的显著抗性。